CSF prion protein concentration and cognition in patients with Alzheimer disease

References

• Thies W, Bleiler L. 2011 Alzheimer disease facts and figures. Alzheimer & Dementia 2011; 7:208 - 44; http://dx.doi.org/10.1016/j.jalz.2011.02.004
   PubMed Web of Science ®Google Scholar
• Parkin ET, Watt NT, Hussain I, Eckman EA, Eckman CB, Manson JC, et al. Cellular prion protein regulates beta-secretase cleavage of the Alzheimer’s amyloid precursor protein. Proc Natl Acad Sci U S A 2007; 104:11062 - 7; http://dx.doi.org/10.1073/pnas.0609621104; PMID: 17573534
   PubMed Web of Science ®Google Scholar
• Um JW, Strittmatter SM. Amyloid-ß induced signaling by cellular prion protein and Fyn kinase in Alzheimer disease. Prion 2012; 6; PMID: 22987042
   PubMed Web of Science ®Google Scholar
• Kudo W, Lee H-P, Zou W-Q, Wang X, Perry G, Zhu X, et al. Cellular prion protein is essential for oligomeric amyloid-β-induced neuronal cell death. Hum Mol Genet 2012; 21:1138 - 44; http://dx.doi.org/10.1093/hmg/ddr542; PMID: 22100763
   PubMed Web of Science ®Google Scholar
• Kessels HW, Nguyen LN, Nabavi S, Malinow R. The prion protein as a receptor for amyloid-beta. Nature 2010; 466:E3 - 4, discussion E4-5; http://dx.doi.org/10.1038/nature09217; PMID: 20703260
   PubMed Web of Science ®Google Scholar
• Laurén J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 2009; 457:1128 - 32; http://dx.doi.org/10.1038/nature07761; PMID: 19242475
   PubMed Web of Science ®Google Scholar
• Saijo E, Scheff SW, Telling GC. Unaltered prion protein expression in Alzheimer disease patients. Prion 2011; 5:109 - 16; http://dx.doi.org/10.4161/pri.5.2.16355; PMID: 21654203
   PubMed Web of Science ®Google Scholar
• Meyne F, Gloeckner SF, Ciesielczyk B, Heinemann U, Krasnianski A, Meissner B, et al. Total prion protein levels in the cerebrospinal fluid are reduced in patients with various neurological disorders. J Alzheimers Dis 2009; 17:863 - 73; PMID: 19542614
   PubMed Web of Science ®Google Scholar
• Manson J, West JD, Thomson V, McBride P, Kaufman MH, Hope J. The prion protein gene: a role in mouse embryogenesis?. Development 1992; 115:117 - 22; PMID: 1353438
   PubMed Web of Science ®Google Scholar
• Sunyach C, Jen A, Deng J, Fitzgerald KT, Frobert Y, Grassi J, et al. The mechanism of internalization of glycosylphosphatidylinositol-anchored prion protein. EMBO J 2003; 22:3591 - 601; http://dx.doi.org/10.1093/emboj/cdg344; PMID: 12853474
   PubMed Web of Science ®Google Scholar
• Fevrier B, Vilette D, Archer F, Loew D, Faigle W, Vidal M, et al. Cells release prions in association with exosomes. Proc Natl Acad Sci U S A 2004; 101:9683 - 8; http://dx.doi.org/10.1073/pnas.0308413101; PMID: 15210972
   PubMed Web of Science ®Google Scholar
• Linden R, Martins VR, Prado MAM, Cammarota M, Izquierdo I, Brentani RR. Physiology of the prion protein. Physiol Rev 2008; 88:673 - 728; http://dx.doi.org/10.1152/physrev.00007.2007; PMID: 18391177
   PubMed Web of Science ®Google Scholar
• Westergard L, Christensen HM, Harris DA. The cellular prion protein (PrP(C)): its physiological function and role in disease. Biochim Biophys Acta 2007; 1772:629 - 44; http://dx.doi.org/10.1016/j.bbadis.2007.02.011; PMID: 17451912
   PubMed Web of Science ®Google Scholar
• Criado JR, Sánchez-Alavez M, Conti B, Giacchino JL, Wills DN, Henriksen SJ, et al. Mice devoid of prion protein have cognitive deficits that are rescued by reconstitution of PrP in neurons. Neurobiol Dis 2005; 19:255 - 65; http://dx.doi.org/10.1016/j.nbd.2005.01.001; PMID: 15837581
   PubMed Web of Science ®Google Scholar
• Maglio LE, Perez MF, Martins VR, Brentani RR, Ramirez OA. Hippocampal synaptic plasticity in mice devoid of cellular prion protein. Brain Res Mol Brain Res 2004; 131:58 - 64; http://dx.doi.org/10.1016/j.molbrainres.2004.08.004; PMID: 15530652
   PubMedGoogle Scholar
• Breitling LP, Müller H, Stegmaier C, Kliegel M, Brenner H. Association of prion protein with cognitive functioning in humans. Exp Gerontol 2012; 47:919 - 24; http://dx.doi.org/10.1016/j.exger.2012.08.001; PMID: 22967749
   PubMed Web of Science ®Google Scholar
• Aguzzi A, Baumann F, Bremer J. The prion’s elusive reason for being. Annu Rev Neurosci 2008; 31:439 - 77; http://dx.doi.org/10.1146/annurev.neuro.31.060407.125620; PMID: 18558863
   PubMed Web of Science ®Google Scholar
• Roucou X, LeBlanc AC. Cellular prion protein neuroprotective function: implications in prion diseases. J Mol Med (Berl) 2005; 83:3 - 11; http://dx.doi.org/10.1007/s00109-004-0605-5; PMID: 15645198
   PubMed Web of Science ®Google Scholar
• Gimbel DA, Nygaard HB, Coffey EE, Gunther EC, Laurén J, Gimbel ZA, et al. Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J Neurosci 2010; 30:6367 - 74; http://dx.doi.org/10.1523/JNEUROSCI.0395-10.2010; PMID: 20445063
   PubMed Web of Science ®Google Scholar
• Alier K, Ma L, Yang J, Westaway D, Jhamandas JH. Aβ inhibition of ionic conductance in mouse basal forebrain neurons is dependent upon the cellular prion protein PrPC. J Neurosci 2011; 31:16292 - 7; http://dx.doi.org/10.1523/JNEUROSCI.4367-11.2011; PMID: 22072680
   PubMed Web of Science ®Google Scholar
• Barry AE, Klyubin I, Mc Donald JM, Mably AJ, Farrell MA, Scott M, et al. Alzheimer’s disease brain-derived amyloid-β-mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion protein. J Neurosci 2011; 31:7259 - 63; http://dx.doi.org/10.1523/JNEUROSCI.6500-10.2011; PMID: 21593310
   PubMed Web of Science ®Google Scholar
• Freir DB, Nicoll AJ, Klyubin I, Panico S, Mc Donald JM, Risse E, et al. Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sites. Nat Commun 2011; 2:336; http://dx.doi.org/10.1038/ncomms1341; PMID: 21654636
   PubMed Web of Science ®Google Scholar
• Chung E, Ji Y, Sun Y, Kascsak RJ, Kascsak RB, Mehta PD, et al. Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer’s disease model mouse. BMC Neurosci 2010; 11:130; http://dx.doi.org/10.1186/1471-2202-11-130; PMID: 20946660
   PubMed Web of Science ®Google Scholar
• Nygaard HB, Strittmatter SM. Cellular prion protein mediates the toxicity of beta-amyloid oligomers: implications for Alzheimer disease. Arch Neurol 2009; 66:1325 - 8; http://dx.doi.org/10.1001/archneurol.2009.223; PMID: 19901162
   PubMed Web of Science ®Google Scholar
• Banks WA, Robinson SM, Diaz-Espinoza R, Urayama A, Soto C. Transport of prion protein across the blood-brain barrier. Exp Neurol 2009; 218:162 - 7; http://dx.doi.org/10.1016/j.expneurol.2009.04.025; PMID: 19422824
   PubMed Web of Science ®Google Scholar
• Doody RS, Massman P, Dunn JK. A method for estimating progression rates in Alzheimer disease. Arch Neurol 2001; 58:449 - 54; http://dx.doi.org/10.1001/archneur.58.3.449; PMID: 11255449
   PubMed Web of Science ®Google Scholar
• Azumi M, Ishizuka S, Fujii M, Sasaki H. Antipsychotics and cognitive function. Psychogeriatrics 2011; 11:79 - 82; http://dx.doi.org/10.1111/j.1479-8301.2011.00372.x; PMID: 21707854
   PubMed Web of Science ®Google Scholar
• Vigen CLP, Mack WJ, Keefe RSE, Sano M, Sultzer DL, Stroup TS, et al. Cognitive effects of atypical antipsychotic medications in patients with Alzheimer’s disease: outcomes from CATIE-AD. Am J Psychiatry 2011; 168:831 - 9; http://dx.doi.org/10.1176/appi.ajp.2011.08121844; PMID: 21572163
   PubMed Web of Science ®Google Scholar
• Ballard C, Patel A, Oyebode F, Wilcock G. Cognitive decline in patients with Alzheimer’s disease, vascular dementia and senile dementia of Lewy body type. Age Ageing 1996; 25:209 - 13; http://dx.doi.org/10.1093/ageing/25.3.209; PMID: 8670554
   PubMed Web of Science ®Google Scholar
• Chapman RM, Mapstone M, Gardner MN, et al. Women have Farther to Fall: Gender Differences Between Normal Elderly and Alzheimer’s Disease in Verbal Memory Engender Better Detection of Alzheimer’s Disease in Women. Journal of the International Neuropsychological Society 2011; 17:654 - 62; http://dx.doi.org/10.1017/S1355617711000452; PMID: 21083962
   PubMed Web of Science ®Google Scholar
• Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007; 6:734 - 46; http://dx.doi.org/10.1016/S1474-4422(07)70178-3; PMID: 17616482
   PubMed Web of Science ®Google Scholar
• McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984; 34:939 - 44; http://dx.doi.org/10.1212/WNL.34.7.939; PMID: 6610841
   PubMed Web of Science ®Google Scholar
• Aebi C. Validierung der neuropsychologischen Testbatterie CERAD-NP: eine Multi- Center Studie. PhD Thesis. Faculty of Humanities. University of Basel. Switzerland. 2002.
   Google Scholar
• Doody RS, Dunn JK, Huang E, Azher S, Kataki M. A method for estimating duration of illness in Alzheimer’s disease. Dement Geriatr Cogn Disord 2004; 17:1 - 4; http://dx.doi.org/10.1159/000074078; PMID: 14560058
   PubMed Web of Science ®Google Scholar